Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_999_Библиотеки_им_академика_М_И_Перельмана
.pdf
320
https://t.me/med1917
37. Brandstrup B, Tønnesen H, Beier-Holgersen R, etal. Effects of intravenous uid restriction on
postoperative complications: comparison of two perioperative uid regimens. A randomized
assessor blinded multi Centre trial. Ann Surg. 2003;238:641–8.
38. Chan STF, Kapadia CR, Johnson AW, etal. Extracellular uid volume expansion and third
space sequestration at the site of small bowel anastomoses. Br J Surg. 1983;70:36–9.
39. Brandstrup B.Restricted intravenous uid therapy in colorectal surgery, results of a clinical
randomised multi centre trial; 2003. https://www.researchgate.net/publication/279931470_
Restricted_intravenous_fluid_therapy_in_colorectal_surgery_Results_of_a_clinical_randomised_multi_centre_trial/link/559e9b0508aea946c06a3671/download. Accessed 28
Aug 2023.
40. Marjanovic G, Villain C, Juettner E, etal. Impact of different crystalloid volume uid regimens
on intestinal anastomotic stability. Ann Surg. 2009;249:181–5.
41. Kulemann B, Timme S, Sifert G, etal. Intraoperative crystalloid overload leads to substantial
inammatory inltration of intestinal anastomosis—a histomorphological analysis. Surgery.
2013;154:596–603.
42. Jacob M, Chappel D, Rehm M. The third space—fact or ction? Best Pract Res Clin
Anaesthesiol. 2009;23:145–57.
43. Cheatham ML, Safcsak K, Brzezinski SJ, Lube MW. Nitrogen balance, protein loss, and the
open abdomen. Crit Care Med. 2007;35(1):127–31.
44. Rehm M, Hulde N, Kammerer T, Meidert AS, Hofmann-Kiefer K.State of the art in uid and
volume therapy : a user-friendly staged concept. Anaesthesist. 2019;68(Suppl 1):1–14.
45. Burlew CC.The open abdomen: practical implications for the practicing surgeon. Am J Surg.
2012;204(6):826–35.
46. Cumin D, Fogarin J, Mitchell SJ, Windsor JA.Perioperative hypothermia in open and laparoscopic colorectal surgery. ANZ J Surg. 2022;92(5):1125–31.
47. Biegner AR, Anderson D, Olson RL, etal. Quantication of insensible water loss associated with insufation of nonhumidied CO2in patients undergoing laparoscopic surgery. J
Laparoendosc Adv Surg Tec A. 1999;9:325–9.
48. Clark RB, Thompson DS, Thompson CH.Prevention of spinal hypotension associated with
cesarean section. Anesthesiology. 1976;45:670–4.
49. Fanelli G, Casati A, Berti M, etal. Incidence of hypotension and bradycardia during integrated
epidural/general anaesthesia. An epidemiologic observational study on 1200 consecutive
patients. Italian Study Group on Integrated Anaesthesia. Minerva Anesthesiol. 1998;64:313–9.
50. Massoth C, Töpel L, Wenk M.Hypotension after spinal anesthesia for cesarean section: how to
approach the iatrogenic sympathectomy. Curr Opin Anaesthesiol. 2020;33(3):291–8.
51. Kinsella SM, Pirlet M, Mills MS, etal. Randomized study of intravenous uid preload before
epidural analgesia during labour. Br J Anaesth. 2000;85:311–3.
52. Kubli M, Shennan AH, Seed PT, etal. A randomised controlled trial of uid pre-loading before
low dose epidural analgesia for labour. Int J Obstet Anesth. 2003;12:256–60.
53. Nishimura N, Kajimoto Y, Kabe T, etal. The effect of volume loading during epidural analgesia. Resuscitation. 1985;13:31–9.
54. Jackson R, Reid JA, Thorburn J.Volume preloading is not essential to prevent spinal-induced
hypotension at caesarean section. Br J Anaesth. 1995;75:262–5.
55. Park GE, Hauch MA, Curlin F, etal. The effects of varying volumes of crystalloid administration before cesarian delivery on maternal hemodynamics and colloid osmotic pressure. Anesth
Analg. 1996;83:299–303.
56. Rout CC, Rocke DA, Levin J, etal. A reevaluation in the role of crystaloid preload in the
prevention of hypotension associated with spinal anesthesia for elective cesarean section.
Anesthesiology. 1993;79:262–9.
57. Rivers E, Nguyen B, Havstad S, etal. Early goal-directed therapy in the treatment of severe
sepsis and septic shock. N Engl J Med. 2001;345:1368–77.
58. Shoemaker WC, Appel PL, Kram HB, etal. Prospective trial of supranormal values of survivors as therapeutic goals in high risk surgical patients. Chest. 1987;94:1176–86.
B. Brandstrup and A. M. Møller

19 Perioperative Fluid Administration and Complications in Emergency…
https://t.me/med1917
59. Navarro LH, Bloomstone JA, Auler JO Jr, etal. Perioperative uid therapy: a statement from
the international Fluid Optimization Group. Perioper Med. 2015;4:1–20.
60. Jones AE, Shapiro NI, Trzeciak S, et al. Emergency Medicine Shock Research Network
(EMShockNet) Investigators. Lactate clearance vs central venous oxygen saturation as goals
of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303:739–46.
61. Wilms H, Mittal A, Haydock MD, et al. A systematic review of goal directed uid therapy:
rating of evidence for goals and monitoring methods. J Crit Care. 2014;29:204–9.
62. Forget P, Lois F, de Kock M.Goal-directed uid management based on the pulse oximeterderived pleth variability index reduces lactate levels and improves uid management. Anesth
Analg. 2010;111:910–4.
63. Lobo SM, Lobo FR, Polachini CA, et al. Prospective, randomized trial comparing uids
and Doputamine optimization of oxygen delivery in high-risk surgical patients. Crit Care.
2006;10:R72.
64. Lobo SMA, Salgado PF, Castillo VGT, etal. Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med. 2000;28:3396–404.
65. Benes J, Chytra I, Altmann P, et al. Intraoperative uid optimization using stroke volume
variation in high risk surgical patients: results of prospective randomized study. Crit Care.
2010;14:1–15.
66. Gan TJ, Soppitt A, Maroof M, etal. Goal-directed intraoperative uid administration reduces
length of hospital stay after major surgery. Anesthesiology. 2002;97:820–6.
67. Lopes MR, Olivera MA, Pereira VOS, etal. Goal-directed uid management based on pulse
pressure variation monitoring during high-risk surgery: a pilot randomized controlled trial.
Crit Care. 2007;11:R100.
68. Mayer J, Boldt J, Mengistu AM, etal. Goal-directed intraoperative therapy based on autocalibrated arterial pressure waveform analysis reduces hospital stay in high-risk surgical patients:
a randomized, controlled trial. Crit Care. 2010;14:1–9.
69. Salzwedel C, Puig J, Carstens A, et al. Perioperative goal-directed hemodynamic therapy
based on radial arterial pulse pressure variation and continuous cardiac index trending
reduces postoperative complications: a multi-center, prospective, randomized study. Crit Care.
2013;17:1–11.
70. Wakeling HG, McFall MR, Jenkins CS, etal. Intraoperative oesophageal Doppler guided uid
management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth.
2005;95:634–42.
71. Buettner M, Schummer W, Huetttemann E, et al. Inuence of systolic-pressure-variationguided intraoperative uid management on organ function and oxygen transport. Br J Anaesth.
2008;101:194–9.
72. Challand C, Struthers R, Sneyd JR, etal. Randomized controlled trial of intraoperative goaldirected uid therapy in aerobically t and unt patients having major colorectal surgery. Br J
Anaesth. 2012;108:53–62.
73. Conway DH, Mayall R, Abdul-Latif MS, etal. Randomised controlled trial investigating the
inuence of intravenous uid titration using oesophageal Doppler monitoring during bowel
surgery. Anaesthesia. 2002;57:845–9.
74. Perner A, Haase N, Guttormsen AB, etal. Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med. 2012;367:124–34.
75. Zheng H, Guo H, Ye J, etal. Goal-directed uid therapy in gastrointestinal surgery in older
coronary heart disease patients: randomized trial. World J Surg. 2013;37:2820–9.
76. Srinivasa S, Taylor MH, Singh PP, et al. Randomized clinical trial of goal-directed uid
therapy within an enhanced recovery protocol for elective colectomy. Br J Anaesth.
2013;100:66–74.
77. Phan TD, D'Sousa B, Rattray MJ, etal. A randomised controlled trial of uid restriction compared to oesophageal Doppler-guided goal-directed uid therapy in elective major colorectal surgery within an Enhanced Recovery After Surgery program. Anaesth Intensive Care.
2014;42:752–60.
321

322
https://t.me/med1917
78. Brandstrup B, Svendsen PE, Rasmussen M, etal. Which goal for uid therapy during colorectal surgery is followed by the best outcome: near maximal stroke volume or zero uid balance?
A clinical randomized double blinded multi centre trial. Eur J Anaesth. 2010;27:4.
79. Wrzosek A, Jakowicka-Wordliczek J, Zajaczkowska R, etal. Perioperative restrictive versus goal-directed uid therapy for adults undergoing major non-cardiac surgery. Cochrane
Database Syst Rev. 2019;12:CD012767.
80. Colantonio L, Claroni C, Fabrizi L, etal. A randomized trial of goal directed vs. standard
uid therapy in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J
Gastrointest Surg. 2015;19:722–9.
81. Warrillow SJ, Weinberg L, Parker F, et al. Perioperative uid prescription, complications and outcomes in major elective open gastrointestinal surgery. Anaesth Intensive Care.
2010;38:259–65.
82. Wuethrich PY, Burchard FC, Thalmann GN, et al. Restrictive deferred hydration combined with preemptive norepinephrine infusion during radical cystectomy reduces postoperative complications and hospitalization time: a randomized clinical trial. Anesthesiology.
2014;120:365–77.
83. National Heart and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical
Trials Network. Comparison of two uid management strategies in acute lung injury. N Engl
J Med. 2006;354:2564–75.
84. Bhaskaran K, Arumugam G, Kumar PV.A prospective randomized comparison study on effect
of perioperative use of chloride liberal intravenous uids versus chloride restricted intravenous
uids on postoperative acute kidney injury in patients undergoing off-pump coronary artery
bypass grafting surgeries. Ann Card Anaesth. 2018;21:413–8.
85. McArdle GT, McAuley DF, McKinley A, etal. Preliminary results of a prospective randomized trial of restrictive versus standard uid regime in elective open abdominal aortic aneuriysm repair. Ann Surg. 2009;250:28–34.
86. Stewart RM, Park PK, Hunt JP, etal. Less is more: improved outcomes in surgical patients
with conservative uid administration and central venous catheter monitoring. J Am Coll Surg.
2009;208:725–37.
87. Myles PS, Bellomo R, Corcoran T, et al. Restrictive versus liberal uid therapy for major
abdominal surgery. N Engl J Med. 2018;378:2263–74.
88. Brandstrup B.Finding the right balance. N Engl J Med. 2018;378:2335–6.
89. Tengberg LT, Bay-Nielsen M, etal. Multidisciplinary perioperative protocol in patients undergoing acute high-risk abdominal surgery. Br J Surg. 2017;104:463–71.
90. Voldby AW, Aaen AA, Loprete R, etal. Perioperative uid administration and complications in
emergency gastrointestinal surgery—an observational study. Perioper Med. 2022;11:9.
91. Brandstrup B, Møller AM.The challenge of perioperative uid management in elderly patients.
Curr Anesthesiol Report. 2019;9:406–13.
92. ERAS Society. ERAS programs; 2019. https://www.erassociety.org/guidelines/list- of-
guidelines/. Accessed 28 Aug 2023.
B. Brandstrup and A. M. Møller

Chapter 20
https://t.me/med1917
The Surgical Critically Ill Patients:
AFocus onDeresuscitation Strategy
MartinRuste , Jean-LucFellahi, andMatthiasJacquet-Lagrèze
Preliminary Concepts
Fluid Overload
The denition of uid overload is heterogeneous in the literature and originates in
the association of a daily positive cumulative uid balance (the difference between
total uid intake and total uid outputs, usually adjusted in percentage of body
weight) with a worse prognosis. From a statistical approach, it is usually described
as an all-or-nothing phenomenon, ranging from 5% to 10% of the patient’s body
weight, without discriminating intravascular and extravascular compartments nor
characterizing the related damaged end-organ [1–3]. Such an approach is questionable as:
– there is no identied threshold effect between cumulative uid balance and prog-
nosis and each 1% of body weight or positive Liter in cumulative uid balance is
associated with an increase in morbimortality [4, 5];
– the various measurement methods of the cumulative uid balance are not accu-
rate nor interchangeable with body weight variation [6–8];
– peripheral edema may coexist with intravascular hypo or hypervolemia [9];
M. Ruste (*) · J.-L. Fellahi · M. Jacquet-Lagrèze
Service d’anesthésie-réanimation, Hôpital Louis Pradel, Hospices Civils de Lyon,
Bron Cedex, France
Faculté de Médecine Lyon Est, Université Claude Bernard Lyon 1, Lyon Cedex 08, France
Laboratoire CarMeN, Inserm UMR 1060, Université Claude Bernard Lyon 1, Lyon, France
e-mail: martin.ruste@chu-lyon.fr; jean-luc.fellahi@chu-lyon.fr;
matthias.jacquet-lagreze@chu-lyon.fr
Switzerland AG 2024
J. Faintuch, S. Faintuch (eds.), Recent Strategies in High Risk Surgery,
https://doi.org/10.1007/978-3-031-56270-9_20
323© The Author(s), under exclusive license to Springer Nature

324
https://t.me/med1917
– the evaluation of the uid overload impact on end-organ function may serve as a
therapeutic trigger and/or target [10].
Recently, experts proposed new denitions for the “uid accumulation,”
related to a pathologic state of overhydration whatever intravascular status and
the “uid accumulation syndrome” as the association between the uid accumulation and impact on end-organ function [10].
M. Ruste et al.
Deresuscitation or De-escalation
A four-phase strategy of uid management was rst described 10years ago in septic
shock [11]. The rst “salvage” or “rescue” phase consists of an aggressive therapy
to restore organ perfusion at the very early management of shock state, which is
then tightly promoted during the rst hours (optimization phase). The following
stabilization phase aims to maintain homeostasis by the way of organ support, titration of uids and vasoactive medications and to initiate a late conservative uid
management inducing a slight negative uid balance. Initially described as de-escalation, the fourth phase consists of achieving a net negative uid balance after circulatory shock resolution to counteract the side effects of uid accumulation. The term
“deresuscitation” is suggested by other authors as a more “active” strategy of uid
removal [10]. This strategy involves uid intake restriction with a forced diuresis or
the application of net ultraltration to remove a large amount of uid over several
days (Fig.20.1). There are no widely admitted nor accurate denitions of the beginning and end of each phase.
If this four-phase approach of uid therapy ts well to the global intensive care
trajectory for a large part of critically ill patients, a myriad of situations is encountered in clinical practice. For example, uid overload may exist without or precede
any circulatory shock (congestive cardiopathy, liver or renal failure, iatrogenia…)
or may develop after initial resuscitation.

20 The Surgical Critically Ill Patients: AFocus onDeresuscitation Strategy
https://t.me/med1917
Fig. 20.1 Four-phase uid management strategy of shock state 1. Salvage or Rescue Phase
(Minutes to Hours) Lifesaving measures to restore a minimal arterial pressure and organ perfusion (aggressive uid therapy, early introduction of Norepinephrine, blood transfusion) 2. Optimization Phase (Hours to Days) Personalized uid therapy (uid
responsiveness assessment), catecholamine administration (echocardiography) and perfusion
maximization (clinical and biological assessment) 3. Stabilization Phase (Days) Providing
organ support and initiate their progressive weaning: decrease in catecholamine support, slight
decrease in uid balance to promote weaning from mechanical ventilation, venous congestion
evaluation and treatment. Minimizing complications 4. De-escalation or deresuscitation phase
(days to weeks) Correction of uid accumulation: uid intake restriction associated with uid
removal by the way of diuretics or ultraltration
325
Pathophysiology ofFluid Overload
Physiologically, uid overload may be dened as a “pathologic accumulation of
water and electrolytes in the body beyond that seen in healthy individuals” [12].
This accumulation originates in an inadequacy between the uid intake and the
outputs, largely mediated by a patient-physician interaction [12]. For example, if a
crystalloid administration is temporarily efcient to increase plasma volume, only
20% of the initially administrated volume persists in intravascular compartment
30min after the administration, with a re-distribution to the extravascular space followed by an elimination phase. Such transfers are moreover highly dependent on
hemodynamic parameters and patient’s related factors (i.e. context sensitive) [13,
14]. The extravasation is reinforced in systemic inammatory state, where the endo-
thelial glycocalyx and tight junction deterioration impaired the regulation of uid

326
https://t.me/med1917
M. Ruste et al.
and electrolytes movements across the capillary membrane [15, 16], promoting a
high capillary permeability clinically traducing by the so-called capillary leak syndrome. There are reasons to believe that it is associated with a quasi-ubiquitarian
impact on end-organ function [17, 18].
Following the four-phase concept of uid management and clinicians’ beliefs
[19], uid overload is inherent to the initial salvage phase responsible for a large
amount of intravenous uid and sodium intake. However, recent ndings challenge
this assumption as volume and sodium overload during the ICU stay are mainly
driven by uid creep (unintentional administration for vehiculate intravenous, oral
or enteral medication) and maintenance uids, much more than resuscitation uids
[20]. It may explain the progressive development of uid overload in the case of
inadequate diuresis as shown in patients with acute kidney injury [5].
Inadequate elimination of uids administrated to critically ill patients is probably multifactorial. The end-organ implied in hydro-electrolytic balance may be
impaired because of tissue injury, hemodynamic impairment or hormonal perturbations. At the ICU admission, 25% of patients were reported to present oliguria in the
rst 24h, and this oliguria persists during the whole ICU stay in almost two out of
three of them [21]. Among patients admitted for sepsis, almost one out of two have
diastolic dysfunction [22] and one out of six a reduced left ventricular ejection fraction (<40%) [23]. Secondary acquired liver injury could concern as many as one out
of three patients in the ICU [24]. Furthermore, several local factors promote the
persistence of interstitial edema. The glycocalyx degradation is not rapidly reversible after the aggression. The extracellular matrix distortion decreases the interstitial pressure. The lymphatic dysfunction reduces the capacity for vascular relling,
which is the main determinant of edema resolution in the low ltration-low resorption revised Starling principle of microvascular uid exchange [25]. All these phenomena are responsible for a vicious circle [26], making the spontaneous resolution
of uid accumulation unlikely or tardy. In this context, “active” uid removal may
decrease the intensity and the exposure duration to uid overload and thus be considered as a full therapeutic tool to enhance organ recovery and prevent complications’ occurrence.
In the particular context of the surgical critically ill patient, various factors predisposing for uid overload may be encountered in the operating room: goaleddirected therapy improves prognosis but requires intravenous uid therapy,
hemorrhage may require blood product administration, surgical trauma or ischemiareperfusion induce systemic inammatory response, uid creep may be related to
medications or the priming of cardiopulmonary bypass. After the surgery, postoperative organ dysfunction (renal, cardiac or liver failures) may be responsible for
inadequate outputs, and postoperative complications may require uid creep, maintenance or resuscitation uids. Data are scarce concerning this population specically, but uid overload >5% could concern more than 10% of the patients admitted
in ICU after surgery [27] and capillary leak syndrome was recently reported in 50%
of a cohort of surgical critically ill patients [28]. A positive cumulative uid balance
is associated with a worse prognosis after cardiac [29, 30] and non-cardiac surgery
[27, 31, 32].

20 The Surgical Critically Ill Patients: AFocus onDeresuscitation Strategy
https://t.me/med1917
327
Fluid Removal: Tolerance andTargets
In deresuscitation strategy, uid removal consists of an intravascular volume withdrawal by the way of diuretics or net ultraltration. Thus, whether the intravascular
volume will keep constant or decrease depends on the vascular relling rate, which
in critically ill patients, as previously discussed, is probably low. Such an assumption is reinforced by the J-shaped association between net ultraltration intensity
and prognosis in patients with continuous renal replacement therapy reported by
several cohort studies [33]. On the one hand, in patients with intravascular hypervolemia, targeting a decrease in circulating blood volume makes sense. Indeed, it
may participate in reducing venous congestion and thus improve end-organ function as the kidney or the liver [34]. But, on the other hand, in patients without
intravascular hypervolemia, decreasing intravascular volume exposes to iatrogenic
hypovolemia and hypoperfusion [33]. In this situation, the adequacy between the
vascular relling rate and the uid removal rate is probably the cornerstone of
hemodynamic tolerance during deresuscitation. However, such an approach
remains simplistic regarding the complexity of the interaction between intravascular volume status and hemodynamic. Various strategies have been proposed to
safely guide the uid removal: passive leg raising predicts arterial hypotension during intermittent hemodialysis with high rate ultraltration [35] and peripheral perfusion index during continuous renal replacement therapy [36]; central venous
pressure and cardiac output may be associated to estimate both efciency and tolerance [37]; clinical and biological peripheral perfusion monitoring allows a more
efcient uid removal without sign of harm [38]. In any event, an individualization
of the uid removal rate associated with a frequent re-assessment of its tolerance
reaches consensus [39, 40].
If applying uid withdrawal to decrease the side effect of uid accumulation
raises the question of how to do it safely, the targets also remain unclear. The dry
weight, an already challenging concept in patients with chronic hemodialysis, may
look like a pipe dream in critically ill patients. Non-accurate or unavailable baseline
weight measures, multifactorial and quick loss of muscle mass and imprecision of
the measure during the ICU stay do not encourage to use it alone. A rigorous cumulative uid balance estimation may help to quantitatively estimate the efciency of
the uid removal strategy. Bio-electrical impedance analysis is a promising noninvasive and easy-to-use method to determine body composition at the bedside.
Several of its derived parameters oriented to estimate uid accumulation are associated with prognosis [41–44]. However, its sensibility seems to be low, the multicompartmental models available are heterogenous, the estimation of the uid status
is not well validated in critically ill patients, a lot of research angles persist and no
interventional study has demonstrated its impact on outcome [43, 45]. An end-organ
approach may be used as a trigger and/or a target to guide uid removal. Fluid
removal decreases intraabdominal pressure and extravascular lung water [46], helps
to decrease left and right ventricular lling pressure accelerating the mechanical
ventilation weaning [47, 48], could improve renal venous congestion and decrease

328
https://t.me/med1917
worsening kidney failure in acute heart failure [49, 50] and may participate to postoperative microcirculation improvement [51]. These factors may be estimated routinely with more or less invasive monitoring as pulmonary artery catheter,
transpulmonary thermodilution, point of care ultrasound evaluation [52, 53] or non-
invasive sublingual device.
M. Ruste et al.
Fluid Removal: with what tools?
Diuretics
A diuretic is a substance that increases the ow of urine, mainly by the way of a
kidney action, allowing the removal of water and electrolytes. A recent large
database cohort study reported an exposition to diuretics in nearly one out of two
critically ill patient. The use was particularly important in patients with a history
of heart failure, under mechanical ventilation or in postoperative care after cardiac surgery. Loop diuretic was by far the most frequently administrated class
and diuretic combinations that concern less than one out of four patients receiving diuretics [54]. The continuous infusion of loop diuretics rather than an intermittent administration and their association with carbonic anhydrase inhibitors
or thiazides could be more efcient to decrease cumulative uid balance but are
associated with more metabolic complications. However, the combination of
loop diuretics with a thiazide decreases the risk for hypernatremia, and the
administration of potassium sparing diuretics may help to avoid hypokalemia at
the cost of decreasing diuresis [55]. These four pharmacological classes of
diuretics are detailed in Table 20.1. Acute kidney injury and norepinephrine
administration should probably not be impediments to diuretic prescription as it
did not alter the outcome for the former [56] and worsen the prognosis for the
latter [57].
Ultraltration
Extracorporeal ultraltration consists of the removal of water, electrolytes and
molecules from the plasma below a certain weight mediated by hydrostatic pressure applied across a dedicated semi-permeable membrane. It is carried out with
a double lumen central venous catheter, continuously or intermittently, and most
of the time in association with renal replacement therapy (rather than isolated).
Isolated ultraltration has no signicant impact on plasma electrolytes, small solutes and proteins, whereas during renal replacement therapy, it contributes to the
exchanges required to maintain homeostasis. In this case, the ultraltrate is totally

20 The Surgical Critically Ill Patients: AFocus onDeresuscitation Strategy
https://t.me/med1917
329
Table 20.1
Site of action NKCC-2
Main effects Loss of water
Molecules Furosemide
Main adverse
events
Cautions for
usage
Main interests
for combination
with loop
diuretics
Diuretics for deresuscitation
Loop diuretics Thiazides
(Loop of
Henle)
+++
Natriuretic +
Kaliuretic ++
Calciuretic
Bumetanide
Torsemide
Metabolic
alkalosis
Hypo/
hypernatremia
Hypokaliemia
Ototoxicity
Resistance
Dysnatremia
Alkalosis
Hypokaliemia
Prefer
continuous
infusion
NCC
(Distal convoluted
tubule)
Loss of water +
Natriuretic ++
Kaliuretic +
2+
Ca
reabsorption
Hydrochlorothizide
Indapamide
Metolazone
Metabolic alkalosis
Hyponatremia
Hypokaliema
Hyponatremia
Hypokaliemia
Efciency to
decrease cumulative
uid balance
Avoiding
hypernatremia
Carbonic
Anhydrase
inhibitors
Carbonic
anhydrase
(Proximal
convoluted
tubule)
Loss of water +
Natriuretic ++
Kaliuretic +
Acetazolamide Amiloride
Metabolic
acidosis
Hypokaliemia
Tolerance after
48h
Respiratory
acidosis
Advance liver
disease
Hyponatremia
Hypokaliemia
Efciency to
decrease
cumulative uid
balance
Potassium sparing
diuretics
ENaC or
mineralocorticoid
receptor
(Distal convoluted
tubule, connecting
tubule, collecting
tubule)
Loss of water +
Natriuretic +
+
K
reabsorption +
Spironolactone
Aldactone
Metabolic acidosis
Hyperkaliemia
Shock state
Hyperkaliemia
(particularly if renal
failure)
Avoiding
hypokaliemia
or not compensated by uid replacement, and the volume subtracted during renal
replacement therapy is called the “net ultraltration” [33]. One of the theoretical
advantages of ultraltration over diuretics is the lack of induced metabolic disorders as frequently observed with the former, and the easy-to-use and precise characteristics of the method. However, independently from the hemodynamic impact
of uid removal per se, renal replacement therapy is not devoid of side effects
[58, 59], and some of them, such as complications related to catheter or blood-
membrane interactions, probably exist in isolated ultraltration. Moreover, recent
Соседние файлы в папке Библиотека им академика М.И. Перельмана
